 U.S.-listed shares of Valneva SE VALN, -3.09 VLA, 10.48 jumped 11.5 in premarket trading on Thursday after the company said that the European Medicines Agency has accepted the application of its COVID-19 vaccine candidate. If the experimental shot receives a positive recommendation from the EMAs Committee for Human Medicinal Products, the company said it expects a decision in June. 